Director/PDMR Shareholding

GlaxoSmithKline PLC 13 October 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned person on 13 October 2005 of an increase in their notional interests in Ordinary Shares at a price of £13.35 per share and Ordinary Share ADRs at a price of $48.00 per ADR following the notional re-investment of the dividend paid to shareholders on 06 October 2005. Mr R Bondy 1,196.184 Ordinary shares Dr W Calhoun 375.531 ADR shares Mr M Dunoyer 450.511 Ordinary shares Dr J P Garnier 3,004.241 ADR shares Dr R Greig 375.531 ADR shares Mr J Heslop 118.103 Ordinary shares Mr D Phelan 578.316 ADR shares Dr D Pulman 395.765 Ordinary shares 184.222 ADR shares Mr D Stout 1,111.569 ADR shares Mr C Viehbacher 578.316 ADR shares Mr A Witty 1,053.708 Ordinary shares Dr T Yamada 901.273 ADR shares Mrs J Younger 271.86 Ordinary shares Mr J Ziegler 578.316 ADR shares The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to a transaction notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 13 October 2005 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings